# Interleukin-1 Blockade for Treatment of Cardiac Sarcoidosis

> **NCT04017936** · PHASE2 · COMPLETED · sponsor: **Virginia Commonwealth University** · enrollment: 17 (actual)

## Conditions studied

- Cardiac Sarcoidosis

## Interventions

- **DRUG:** Anakinra

## Key facts

- **NCT ID:** NCT04017936
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-23
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-06-30
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2025-08-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04017936

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04017936, "Interleukin-1 Blockade for Treatment of Cardiac Sarcoidosis". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04017936. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*